Literature DB >> 9625176

Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen.

D A Scudiero, A Monks, E A Sausville.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9625176     DOI： 10.1093/jnci/90.11.862

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  34 in total

1.  Short tandem repeat profiling provides an international reference standard for human cell lines.

Authors:  J R Masters; J A Thomson; B Daly-Burns; Y A Reid; W G Dirks; P Packer; L H Toji; T Ohno; H Tanabe; C F Arlett; L R Kelland; M Harrison; A Virmani; T H Ward; K L Ayres; P G Debenham
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

2.  Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties.

Authors:  James M Rae; Susan J Ramus; Mark Waltham; Jane E Armes; Ian G Campbell; Robert Clarke; Robert J Barndt; Michael D Johnson; Erik W Thompson
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

3.  LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines.

Authors:  Erik W Thompson; Mark Waltham; Susan J Ramus; Anne-Marie Hutchins; Jane E Armes; Ian G Campbell; Elizabeth D Williams; Phillip R Thompson; James M Rae; Michael D Johnson; Robert Clarke
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Essential role for gene profiling analysis in the authentication of human cell lines.

Authors:  Kaori Yoshino; Emi Iimura; Kaoru Saijo; Shigeru Iwase; Kaoru Fukami; Tadao Ohno; Yuichi Obata; Yukio Nakamura
Journal:  Hum Cell       Date:  2006-02       Impact factor: 4.174

5.  The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells.

Authors:  Andrew J Wilson; Edward Holson; Florence Wagner; Yan-Ling Zhang; Daniel M Fass; Stephen J Haggarty; Srividya Bhaskara; Scott W Hiebert; Stuart L Schreiber; Dineo Khabele
Journal:  Cancer Biol Ther       Date:  2011-09-15       Impact factor: 4.742

6.  Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer.

Authors:  Panagiotis A Konstantinopoulos; Andrew J Wilson; Jeanette Saskowski; Erica Wass; Dineo Khabele
Journal:  Gynecol Oncol       Date:  2014-03-11       Impact factor: 5.482

7.  Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer.

Authors:  Joseph A Ludwig; Gergely Szakács; Scott E Martin; Benjamin F Chu; Carol Cardarelli; Zuben E Sauna; Natasha J Caplen; Henry M Fales; Suresh V Ambudkar; John N Weinstein; Michael M Gottesman
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

8.  Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization.

Authors:  Joseph M Langenhan; Noël R Peters; Ilia A Guzei; F Michael Hoffmann; Jon S Thorson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-16       Impact factor: 11.205

9.  Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib.

Authors:  Andrew J Wilson; Kofi Sarfo-Kantanka; Toby Barrack; Alexandra Steck; Jeanette Saskowski; Marta A Crispens; Dineo Khabele
Journal:  Gynecol Oncol       Date:  2016-07-19       Impact factor: 5.482

10.  Molecular mechanisms of drug resistance in single-step and multi-step drug-selected cancer cells.

Authors:  Anna Maria Calcagno; Suresh V Ambudkar
Journal:  Methods Mol Biol       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.